UBS Starts CVS Health (CVS) at Buy

October 6, 2016 6:53 AM EDT
Get Alerts CVS Hot Sheet
Price: $87.30 --0%

Rating Summary:
    22 Buy, 7 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 9 | New: 8
Trade CVS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

UBS initiates coverage on CVS Health (NYSE: CVS) with a Buy rating and a price target of $107.00.

Analyst Michael Cherny commented, "We are initiating coverage of CVS Health with a Buy rating and a $107 price target. CVS continues to improve health outcomes through an integrated approach to care management, leveraging the service offering of the PBM with its integrated pharmacy network, further supplemented by ancillary services within the retail setting (such as MinuteClinic). This integrated business model has driven multiple years of share gains, particularly with regards to the PBM business as well as outsized growth in specialty (outperforming the market). All-in, this share gain success has led to sustainable enterprise profit growth which, combined with capital deployment, has given CVS low/mid-teens EPS growth, an impressive metric for a mega cap company."

For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.

Shares of CVS Health closed at $86.20 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities


Add Your Comment